Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Directions for future research.

[No authors listed]

Postgrad Med. 2003 Dec;114(6 Suppl Managing Metabolic):85-6. doi: 10.3810/pgm.12.2003.suppl31.186. Review.

PMID:
19667657
2.

Metabolic studies of atypical antipsychotic agents and diabetes.

[No authors listed]

Postgrad Med. 2003 Dec;114(6 Suppl Managing Metabolic):72-9. doi: 10.3810/pgm.12.2003.suppl31.182. Review.

PMID:
19667654
3.

[Atypical antipsychotics and metabolic syndrome].

Baranyi A, Yazdani R, Haas-Krammer A, Stepan A, Kapfhammer HP, Rothenhäusler HB.

Wien Med Wochenschr. 2007;157(11-12):255-70. Review. German.

PMID:
17915438
4.

The relationship between severe mental illness and diabetes.

[No authors listed]

Postgrad Med. 2003 Dec;114(6 Suppl Managing Metabolic):40-5. doi: 10.3810/pgm.12.2003.suppl31.177. Review.

PMID:
19667652
5.

Antipsychotics and diabetes: case reports and cohort studies.

[No authors listed]

Postgrad Med. 2003 Dec;114(6 Suppl Managing Metabolic):59-71. doi: 10.3810/pgm.12.2003.suppl31.181. Review.

PMID:
19667653
6.

Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring.

De Hert M, van Eyck D, De Nayer A.

Int Clin Psychopharmacol. 2006 Mar;21 Suppl 2:S11-5. Review.

PMID:
16601508
7.

Dosing atypical antipsychotics.

Cutler A, Ball S, Stahl SM.

CNS Spectr. 2008 May;13(5 Suppl 9):1-16. Review.

PMID:
18496483
8.

Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.

Schneiderhan ME, Batscha CL, Rosen C.

Pharmacotherapy. 2009 Aug;29(8):975-87. doi: 10.1592/phco.29.8.975.

PMID:
19637951
9.

A prospective study of glycaemic status in anti-psychotic-treated patients.

Mackin P, Bishop D, Watkinson HM, Ferrier IN.

J Psychopharmacol. 2008 Jul;22(5):563-6. doi: 10.1177/0269881107081532. Epub 2008 Jan 21.

PMID:
18208918
10.

The relationship between severe mental illness and obesity.

[No authors listed]

Postgrad Med. 2003 Dec;114(6 Suppl Managing Metabolic):28-39. doi: 10.3810/pgm.12.2003.suppl31.176. Review.

PMID:
19667651
11.

[Inappropriate prescribing of antipsychotics to people with a mental disability and aggressive behavioural disorders].

Stolker JJ, Scheifes A, Egberts AC, Heerdink ER.

Ned Tijdschr Geneeskd. 2008 Jul 5;152(27):1501-2. Dutch.

PMID:
18681357
12.

Development of guidelines for preventing and managing obesity and diabetes in mentally ill patients.

Gupta S, Frank BL.

J Clin Psychiatry. 2004 Aug;65(8):1149. No abstract available.

PMID:
15323609
13.

Atypical antipsychotics and weight gain.

[No authors listed]

Postgrad Med. 2003 Dec;114(6 Suppl Managing Metabolic):46-58. doi: 10.3810/pgm.12.2003.suppl31.180. Review.

PMID:
19667655
14.

[Atypical antipsychotics for elderly patients: to prescribe or to ban?].

Rollini M, Schulz P.

Rev Med Suisse. 2008 Apr 16;4(153):979-80, 982-4. French.

PMID:
18549086
15.

[Internist management of mental disorders].

Oberpichler-Schwenk H.

Med Monatsschr Pharm. 2010 Feb;33(2):37. German. No abstract available.

PMID:
20184261
16.

Antipsychotic drugs & their side effects.

Jaco R.

Indian J Med Res. 2009 Feb;129(2):208-9; author reply 209. No abstract available.

PMID:
19293453
18.

[25 years antipsychotics: back to the future?].

Denys D, de Haan L.

Tijdschr Psychiatr. 2008;50 Spec no.:105-9. Review. Dutch.

19.

Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns.

Vitiello B, Correll C, van Zwieten-Boot B, Zuddas A, Parellada M, Arango C.

Eur Neuropsychopharmacol. 2009 Sep;19(9):629-35. doi: 10.1016/j.euroneuro.2009.04.008. Epub 2009 May 24. Review.

PMID:
19467582
20.

Introduction: cardiovascular disease and metabolic risk factors in patients with mental illness.

Newcomer JW.

CNS Spectr. 2008 Jun;13(6 Suppl 10):1-14. No abstract available.

PMID:
18567978
Items per page

Supplemental Content

Write to the Help Desk